menu
    • menu

    Company profile for SaNOtize

    NEW Drugs in Dev: 1
    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    USP reference standards; highly characterized specimens of drug substances, impurities, excipients, degradation products & more.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Guizhou Utide Biotechnology Co., Ltd. - Specialized GMP manufacturing for next-generation GLP-1 peptide APIs.

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SaNOtize Research & Development Corp. is a biotech company based in Vancouver, BC working to commercialize the multi-faceted antimicrobial properties of a liquid producing nitric oxide. The company has developed and patented a Nitric Oxide Releasing Solution platform technology (NORSTM) to treat and prevent microbial infections.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SaNOtizeCanada Flag
    Country
    Country
    Canada
    Address
    Address
    8755 Ash St, Vancouver, British Columbia V6P 6T3, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sanotize.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sanotize-research-and-development-corp/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    PBP World Meeting

    Not Confirmed

    envelop Contact Supplier

    PBP World Meeting

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SaNOtize’s Board Appoints Steven Basta as New Chief Executive Officer
    SaNOtize’s Board Appoints Steven Basta as New Chief Executive Officer

    27 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230925232677/en

    BUSINESSWIRE
    27 Sep 2023
    Share Share
    SaNOtize Announces Inaugural Scientific Advisory Board
    SaNOtize Announces Inaugural Scientific Advisory Board

    24 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230124005488/en

    BUSINESSWIRE
    24 Jan 2023
    Share Share
    SaNOtize Names John Sharp Chief Financial Officer
    SaNOtize Names John Sharp Chief Financial Officer

    17 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230117005143/en

    BUSINESSWIRE
    17 Jan 2023
    Share Share
    SaNOtize Announces Funding to Advance Nitric Oxide-Based Therapeutics
    SaNOtize Announces Funding to Advance Nitric Oxide-Based Therapeutics

    24 Aug 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220824005114/en

    BUSINESSWIRE
    24 Aug 2022
    Share Share
    SaNOtize moves to carve new OTC market for COVID therapy
    SaNOtize moves to carve new OTC market for COVID therapy

    25 Jul 2022

    // Max Bayer FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/sanotize-plans-phase-3-covid-prevention-trial-us-rather-treatment-regulators-ice-viral-load

    Max Bayer FIERCEBIOTECH
    25 Jul 2022
    Share Share
    SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days
    SaNOtize Nitric Oxide Nasal Spray Reduced Viral Load by 99% within Two Days

    13 Jul 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220713005181/en

    BUSINESSWIRE
    13 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search